E.I. Du Pont De Nemours & Co. v. NV

335 F. Supp. 3d 657
CourtDistrict Court, D. Delaware
DecidedAugust 15, 2018
DocketCivil Action No. 17-1577
StatusPublished
Cited by7 cases

This text of 335 F. Supp. 3d 657 (E.I. Du Pont De Nemours & Co. v. NV) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
E.I. Du Pont De Nemours & Co. v. NV, 335 F. Supp. 3d 657 (D. Del. 2018).

Opinion

Goldberg, District Judge

This patent infringement and breach of contract case arises from a business relationship gone awry. Plaintiff, E.I. du Pont de Nemours and Company ("DuPont"), has filed a Motion for a Temporary Restraining Order and Preliminary Injunction, requesting that I enjoin Defendants, Agfa-Gavaert NV ("the Parent"), Agfa Graphics NV ("the Belgian Subsidiary"), and Agfa Corporation ("the Delaware Subsidiary") from affirmatively using certain materials in a pending patent proceeding in Germany. The Parent and Belgian Subsidiary, both based in Belgium, have filed a Motion to Dismiss pursuant to Federal Rule of Evidence 12(b)(2), contending that I do not have personal jurisdiction over them.

For the reasons that follow, I will grant the Parent and Belgian Subsidiary's Motion to Dismiss and deny DuPont's Motion for a Temporary Restraining Order as moot.1

I. PROCEDURAL AND FACTUAL BACKGROUND2

Although multi-faceted, the dispute between the parties centers around several patents held by the Belgian Subsidiary, including the '759 Patent, which is the subject of this lawsuit.

DuPont filed its original Complaint in the District of Delaware on November 3, *6622017, and subsequently filed an Amended Complaint on November 17, 2017.3 DuPont brings the following causes of action: declaratory judgment of invalidity of the '759 Patent (Count I); declaratory judgment of non-infringement of the '759 Patent (Count II); declaratory judgment of implied license of the '759 patent (Count III); declaratory judgment of equitable estoppel (Count IV); unfair competition claim under Section 43(A) of the Lanham Act, 15 U.S.C. § 1125 (Count V); declaratory judgment of patent exhaustion (Count VI); violation of Delaware Deceptive Trade Practices Act (Count VII); violation of Delaware Consumer Fraud Act (Count VIII); breach of contract and covenant of good faith and fair dealing (Count IX); copyright infringement (Count X); and breach of website terms of use (Count XI).

DuPont filed its Motion for a Temporary Restraining Order and Preliminary Injunction on December 6, 2017. On January 24, 2018, the Parent and Belgian Subsidiary filed a Motion to Dismiss pursuant to Federal Rule of Evidence 12(b)(2).4

A. The Parties

DuPont, a corporation that is a wholly owned subsidiary of DowDuPont, Inc., manufactures and supplies Cyrel® Flexographic Printing Plates and Equipment. These plates look similar to large rubber stamps and are "used to print color images of flexible labels and packaging for hundreds of everyday items, including potato chip bags, frozen vegetable bags, milk cartons, candy bar wrappers, and cereal boxes." DuPont offers a line of both digital and analog flexographic printing plates suitable for thermal development, as well as corresponding thermal development processing equipment under the trade name Cyrel® FAST. (Am. Compl. ¶¶ 1, 19.)

"AGFA" is the collective name used by DuPont for the Parent, Belgian Subsidiary, and Delaware Subsidiary.5 The Parent is a Belgian public limited company with its principal place of business in Mortsel, Belgium. DuPont alleges that it is the parent company to several "wholly owned agent-subsidiaries," through which it "centrally operates its Agfa Graphics Division."6 The Belgian Subsidiary, is a *663public limited company with its principal place of business in Mortsel, Belgium.7 It is a wholly owned subsidiary of the Parent, and according to DuPont, operates as "part of, and with and under the dominion and control of [the Parent] and/or [Parent's] Graphics Division." The Belgian Subsidiary is the assignee of European Patent No. 1,170,121 B1, titled "Direct-to-plate flexographic printing plate precursor" ("the EP '121 patent"), the German Patent DE 600,00237 T2 ("the German Patent"), and United States Patent No. 6,551,759 ("the '759 Patent").8 Finally, the Delaware Subsidiary is a wholly owned subsidiary of the Parent organized under the laws of Delaware. DuPont alleges that the Delaware Subsidiary "operates as part of, and with and under the control of [the Parent] or [the Belgian Subsidiary], and/or AGFA Graphics Division." (Id. ¶¶ 2, 4-6, 20-21.)

B. Litigation History Between the Parties

On March 25, 2003, DuPont challenged the EP '121 Patent through what is referred to as an "Opposition" in the European Patent Office ("the EPO"). On April 26, 2007, the Opposition Division of the EPO revoked the EP '121 Patent for insufficient disclosure. The Board of Appeals of the EPO set aside this decision on July 23, 2010 and referred it back to the Opposition Division. On February 1, 2017, the Opposition Division rejected DuPont's request that it revoke the reinstated EP '121 Patent. DuPont appealed this rejection on April 19, 2017 and was still waiting for a decision when it filed the Amended Complaint in this case. (Id. ¶ 22.) DuPont notified me by correspondence on June 1, 2018 that it had withdrawn its appeal in the EPO.

In or about 2005, "AGFA," through the Belgian Subsidiary, informed DuPont of its position that some of DuPont's Cyrel® FAST flexographic printing plates and corresponding equipment infringed the EP '121 Patent in Europe and the '759 Patent in the United States. DuPont responded that the EP '121 Patent was invalid. DuPont and "AGFA" subsequently began negotiating for a license or sale of the '121 Patent and related patents, however, no agreement was reached and the parties suspended negotiations until the EP '121 Patent appeal was resolved before the EPO. (Id. ¶¶ 23-24.)

DuPont alleges that beginning in 2011, DuPont and "AGFA," through the Delaware Subsidiary, entered into an initial distribution and marketing agreement ("the US Agreement"), which was last renewed and signed in 2016. According to DuPont, the US Agreement authorized "AGFA" as a marketer and distributor in the United States for certain DuPont Cyrel® flexographic plates and equipment. Pursuant to this agreement, "AGFA" agreed to promote, sell, and provide customer service for Cyrel® products. (Id. ¶¶ 27-31.)

DuPont contends that pursuant to the US Agreement, to facilitate the promotion, marketing, distribution, and related support for DuPont's Cyrel® products, DuPont authorized "AGFA" to provide DuPont's written, recorded, and/or digitally *664available materials to "AGFA's" contractually assigned Cyrel® customers and potential customers, under the following terms and conditions:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
335 F. Supp. 3d 657, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ei-du-pont-de-nemours-co-v-nv-ded-2018.